Product Information
POTASSIUM CL ER 8 MEQ TABLET is a generic product labeled by Granules Pharmaceuticals Inc., priced at $0.1020 per EA under NDC 70010002101. Its NADAC has been published 276 times since May 12, 2021.
FDA first approved this application on Mar 4, 2020. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
600 mg/1
Manufacturer
Granules Pharmaceuticals Inc.NDC
70010002101
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
POTASSIUM CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211797FDA Approved
3/4/2020
TE Code
AB2
On Market Since
10/22/2020
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CL ER 8 MEQ TABLET has been published 276 times since May 12, 2021, and over the history we have for it it has declined 42.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1020 per EA |
|---|---|
| All-time high | $0.2037 (Jun 16, 2021) |
| All-time low | $0.1020 (Aug 19, 2026) |
| 52-week high | $0.1413 |
| 52-week low | $0.1020 |
| Median price | $0.1399 |
| Average price | $0.1454 |
| Largest weekly change | -39.3% (Apr 17, 2024) |
| Weeks tracked | 276 |
| Tracking since | May 12, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the POTASSIUM CHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of POTASSIUM CL ER 8 MEQ TABLET?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL ER 8 MEQ TABLET, manufactured by Granules Pharmaceuticals Inc., is $0.1020 per EA (NDC 70010002101), effective Aug 19, 2026.
How has the price of POTASSIUM CL ER 8 MEQ TABLET changed over time?
Over the history we have for it, the NADAC for POTASSIUM CL ER 8 MEQ TABLET has declined 42.4%. It has been tracked across 276 weekly CMS publications since May 12, 2021.
What are the highest and lowest recorded NADAC prices for POTASSIUM CL ER 8 MEQ TABLET?
Since May 12, 2021, the NADAC for POTASSIUM CL ER 8 MEQ TABLET has ranged from a low of $0.1020 (Aug 19, 2026) to a high of $0.2037 (Jun 16, 2021), with a median of $0.1399 per EA.
Are there cheaper alternatives to POTASSIUM CL ER 8 MEQ TABLET?
No other NADAC-published product currently shares the active ingredient and strength of POTASSIUM CL ER 8 MEQ TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures POTASSIUM CL ER 8 MEQ TABLET?
POTASSIUM CL ER 8 MEQ TABLET (NDC 70010002101) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.